Related content

Treating comorbid substance use disorders in schizophrenia

By Lubman Dan I.   King Joel A.   Castle David J.  

International Review of Psychiatry, Vol. 22, Iss. 2, 2010-01 ,pp. : 191-201

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Pharmacotherapy for Comorbid Major Depression and Substance Use Disorders: A review

By  

Current Psychiatry Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 14-27

Bentham Science Publishers

Access to resources Recommend Favorite

Lifetime Diagnosis of Major Depression as a Multivariate Predictor of Treatment Outcome for Inpatients with Substance Use Disorders from Abstinence-Based Programs

By Miller N.S.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 09, Iss. 3, 1997-09 ,pp. : 127-137

Springer Publishing Company

Access to resources Recommend Favorite

Epidemiological Associations between Gambling Behavior, Substance Use & Mood and Anxiety Disorders

By el-Guebaly Nady   Patten Scott   Currie Shawn   Williams Jeanne   Beck Cynthia   Maxwell Colleen   Wang Jian  

Journal of Gambling Studies, Vol. 22, Iss. 3, 2006-09 ,pp. : 275-287

Springer Publishing Company

Access to resources Recommend Favorite

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

By HGDH Research Group   Green A.I.   Tohen M.F.   Hamer R.M.   Strakowski S.M.   Lieberman J.A.   Glick I.   Scott Clark W.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 125-135

Elsevier

Access to resources Recommend Favorite